Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes
Korean Journal of Ophthalmology
; : 46-55, 2020.
Artículo
en Inglés
| WPRIM (Pacífico Occidental)
| ID: wpr-782236
Biblioteca responsable:
WPRO
ABSTRACT
0.05). Mean changes in central macular thickness showed significant differences at 1 and 4 months postoperatively (−1.44 ± 11.72 and 10.44 ± 22.48 µm in bromfenac group vs. 47.19 ± 70.24 and 31.69 ± 48.04 µm in control group, p 0.05).CONCLUSIONS:
Treatment with 0.1% bromfenac sodium hydrate ophthalmic solution showed good efficacy for preventing cystoid macular edema early after cataract surgery in patients with diabetes.
Texto completo:
Disponible
Base de datos:
WPRIM (Pacífico Occidental)
Asunto principal:
Sodio
/
Catarata
/
Agudeza Visual
/
Antiinflamatorios no Esteroideos
/
Edema Macular
/
Estudios Retrospectivos
/
Diabetes Mellitus
Tipo de estudio:
Estudio observacional
Límite:
Humanos
Idioma:
Inglés
Revista:
Korean Journal of Ophthalmology
Año:
2020
Tipo del documento:
Artículo
